n(g)-iminoethylornithine has been researched along with Diabetes Mellitus, Type 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bizjak, DA; Bloch, W; Brinkmann, C; Grau, M | 1 |
| Emanueli, C; Fortunato, O; Madeddu, P; Mangialardi, G; Monopoli, A; Ongini, E; Spinetti, G | 1 |
2 other study(ies) available for n(g)-iminoethylornithine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Increase in Red Blood Cell-Nitric Oxide Synthase Dependent Nitric Oxide Production during Red Blood Cell Aging in Health and Disease: A Study on Age Dependent Changes of Rheologic and Enzymatic Properties in Red Blood Cells.
Topics: Adult; Arginase; Biomarkers; Centrifugation, Density Gradient; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Erythrocyte Aging; Erythrocyte Deformability; Erythrocyte Volume; Erythrocytes; Health; Hemorheology; Humans; Linear Models; Metabolome; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Ornithine; Phosphatidylserines | 2015 |
Nitric oxide-donating statin improves multiple functions of circulating angiogenic cells.
Topics: Aged; Anticholesteremic Agents; Apoptosis; Benzoates; Cardiovascular Agents; Cardiovascular Diseases; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellular Senescence; Diabetes Mellitus, Type 2; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Leukocytes, Mononuclear; Male; Middle Aged; Neovascularization, Physiologic; Nitrates; Nitric Oxide Donors; Nitric Oxide Synthase Type III; Ornithine; Proto-Oncogene Proteins c-akt; Pyrroles; Stem Cells | 2011 |